Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Nature Reviews. Neuroscience|August 19, 2010
The neurobiology of psychedelic drugs: implications for the treatment of mood disordersFranz X Vollenweider, Michael KometerNeurophotonics|December 7, 2022
Psychedelics and fNIRS neuroimaging: exploring new opportunitiesFelix Scholkmann, Franz X VollenweiderCurrent Topics in Behavioral Neurosciences|December 1, 2016
Serotonergic Hallucinogen-Induced Visual Perceptual AlterationsMichael Kometer, Franz X VollenweiderNature Reviews. Neuroscience|September 15, 2020
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disordersFranz X Vollenweider, Katrin H PrellerPharmacopsychiatry|January 26, 2022
Classic Psychedelic Drugs: Update on Biological MechanismsFranz X Vollenweider, John W SmallridgeHuman Psychopharmacology|October 31, 2002
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studiesMatthias E. Liechti, Franz X. VollenweiderFrontiers in Psychiatry|December 19, 2019
Modulation of Social Cognition <i>via</i> Hallucinogens and "Entactogens"Katrin H Preller, Franz X VollenweiderTrends in Pharmacological Sciences|December 17, 2008
Serotonin research: contributions to understanding psychosesMark A Geyer, Franz X VollenweiderCurrent Topics in Behavioral Neurosciences|December 28, 2016
Phenomenology, Structure, and Dynamic of Psychedelic StatesKatrin H Preller, Franz X VollenweiderThe World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 12, 2010
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonistsPatrik Roser, Franz X Vollenweider, Wolfram KawohlPageof 12